Lupin launches penicillamine tablets USP
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
Be One is a 100% Ayurvedic health and wellness supplement.
Tavaborole Topical Solution, 5%, is an oxaborole antifungal.
The country’s strength lies not just in technology availability but in adoption behaviour
Medanta expanded its bed capacity by 20% during the year
Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Subscribe To Our Newsletter & Stay Updated